Antimicrobial resistance (AMR) is emerging as the next potential pandemic. Different
microorganisms, including the bacteria Acinetobacter baumannii, Clostridioides difficile …

Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …

Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …

Of all the ESKAPE pathogens, carbapenem-resistant and multidrug-resistant Acinetobacter
baumannii is the leading cause of hospital-acquired and ventilator-associated pneumonia …

Deciphering the virulence factors, regulation, and immune response to Acinetobacter
baumannii infection Acinetobacter baumannii is a gram-negative multidrug-resistant …

The continuous emergence of multidrug-resistant pathogens evoked the development of
innovative approaches targeting virulence factors unique to their pathogenic cascade …

Conventionally used antibiotics are present in low concentrations at the infection site and
require multiple administrations to sustain a continuous bactericidal effect, which not only …

The objective of this study was to assess the effectiveness of polydopamine nanoparticles
(PDANPs) as a delivery system for intranasal antigen administration to prevent …

Vaccines often require adjuvants to be effective. Traditional adjuvants, like alum, activate the
immune response but in an uncontrolled way. Newer adjuvants help to direct the immune …

Acinetobacter baumannii infections have become an emerging health concern in hospitals
across the world and are often associated with nosocomial infections with poorer clinical …